CD8A and neoplasm: Vaccination with hgp10025–33-pulsed bm12 mBMDCs resulted in decreased tumor weight and increased infiltrating hgp100/H2Db tetramer–specific CD69+CD8+ T cells 14 days after B16-F10 inoculation (Figure 1, F and G; tumor growth curves until the harvesting are shown in Supplemental Figure 3, A and B).